These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The use of perfluorochemicals during open heart surgery. Kanter KR; Gardner TJ Int Anesthesiol Clin; 1985; 23(1):105-14. PubMed ID: 3980101 [TBL] [Abstract][Full Text] [Related]
13. Perfluorocarbons in the twenty-first century: clinical applications as transfusion alternatives. Spence RK Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):367-80. PubMed ID: 7493058 [TBL] [Abstract][Full Text] [Related]
14. Reduction in air bubble size using perfluorocarbons during cardiopulmonary bypass in the rat. Yoshitani K; de Lange F; Ma Q; Grocott HP; Mackensen GB Anesth Analg; 2006 Nov; 103(5):1089-93. PubMed ID: 17056937 [TBL] [Abstract][Full Text] [Related]
16. Blood substitutes and oxygen therapeutics: an overview and current status. Jahr JS; Nesargi SB; Lewis K; Johnson C Am J Ther; 2002; 9(5):437-43. PubMed ID: 12237737 [TBL] [Abstract][Full Text] [Related]
17. Perfluorocarbon administration during cardiopulmonary bypass in rats: an inflammatory link to adverse outcome? de Lange F; Yoshitani K; Proia AD; Mackensen GB; Grocott HP Anesth Analg; 2008 Jan; 106(1):24-31, table of contents. PubMed ID: 18165547 [TBL] [Abstract][Full Text] [Related]
18. Increased antioxidant capacity, suppression of free radical damage and erythrocyte aggrerability after combined application of alpha-tocopherol and FC-43 perfluorocarbon emulsion in early postburn period in rats. Bekyarova G; Yankova T; Galunska B Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):629-41. PubMed ID: 8922232 [TBL] [Abstract][Full Text] [Related]